|Slideshows|May 4, 2017

Epilepsy Highlights: AAN 2017

Highlights: imaging the temporal dynamics & cellular architecture of seizures in Dravet syndrome, & reducing risk of spontaneous fetal loss.

Studies chosen as the best of epilepsy at AAN 2017 included an examination of the structure of seizures in a mouse model of Dravet syndrome, a look at seizure triggers, the impact of unplanned pregnancy on spontaneous fetal loss, and a review studying the feasibility of extrapolating adjunctive AED efficacy data from adults to a pediatric population.

Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.

Subscribe Now!

Epilepsy Highlights: AAN 2017

Newsletter

Related Content

This Week on NeurologyLive® — November 3, 2025

Alexander Gold, MD, on Adrabetadex’s Impact in Infantile-Onset Niemann-Pick C

Designing the Phase 3 EMPEROR Trial and Future Considerations

NeurologyLive® Friday 5 — October 31, 2025

Zorevunersen’s Additive Efficacy in Patients on Established Antiseizure Medications

Latest CME

Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice

Unlocking the Future of Glioma Care: Integrating Recent Advances to Personalize Treatment

Patient, Provider, and Caregiver Connection™: Pediatric Myasthenia Gravis—Current Treatment and Emerging Concepts

Mind Moments™: Optimizing Management for Patients with Generalized Myasthenia Gravis

SimulatED™: Understanding the Role of Genetic Testing in Patient Selection for Anti-Amyloid Therapy

Cases and Conversations™: Navigating the Complexities of Managing Myasthenia Gravis in Pediatric and Pregnant Patient Populations

Identifying and Treating CIDP in the Modern Era

Cases and Conversations™: Little Voices, Big Challenges – Comprehensive Care for Pediatric Spinal Muscular Atrophy

A Breath of Strength: Managing Cancer Associated LEMS and Lung Cancer as One

Striking the Right Nerve: Managing Cancer Associated LEMS in Lung Cancer Patients

Patient, Provider, and Caregiver Connection: Improving Diagnosis and Care for Adolescent Myasthenia Gravis Patients – A New Frontier

A New Era in NMOSD Treatment: Optimizing Therapeutic Transitions and Reducing Patient Burden

PER Podcast™: Maximizing the Multidisciplinary Care Outcomes of Patients with Amyotrophic Lateral Sclerosis (ALS)

PER Podcast™: Best Strategies for Approaching the Diagnosis of Amyotrophic Lateral Sclerosis (ALS)

PER Postgame™: Updates from ANNA in the Management of IgA Nephropathy

Patient, Provider, and Caregiver Connection: Turning a New Leaf in Acute Pain Management – How Recent Advancements Impact the Treatment Paradigm

Rewiring Recovery: Evidence-Based Approaches to Managing Chronic Inflammatory Demyelinating Polyneuropathy

Shining a Light on an Ultra-Rare Disease – A Closer Look at Thymidine Kinase 2 Deficiency (TK2d)

Identifying and Treating Generalized Myasthenia Gravis in the Modern Era

Addressing Unmet Needs for Patients With Spinal Muscular Atrophy—Understanding Patient Challenges and Management Approaches

Expert Illustrations & Commentaries™: Visualizing the Role of Dystrophin Dysregulation as a Therapeutic Target in Duchenne Muscular Dystrophy and MD STARnet

Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights

New Phase 3 Study to Evaluate Remibrutinib in Generalized Myasthenia Gravis Treatment

Early-Stage Study to Test CD19 CAR T-Cell Therapy YTB323 in Myasthenia Gravis

FDA Approves Doxecitine and Doxribtimine Combination Therapy as First Treatment for Thymidine Kinase 2 Deficiency

Jessica Neil, PA, on the Evolution of Patients With Headache

Surveying Global Nursing Needs for Patients With Generalized Myasthenia Gravis: Amy Perrin Ross, APN, MSN, CNRN, MSCN